For help on how to get the results you want, see our search tips.
4 results
Categories
Human Remove Human filter
Medicine
Referrals Remove Referrals filter
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Withdrawn applications Remove Withdrawn applications filter
Summaries of opinion Remove Summaries of opinion filter
Medicine type
Additional monitoring Remove Additional monitoring filter
Orphan medicine Remove Orphan medicine filter
Biosimilar Remove Biosimilar filter
Conditional approval Remove Conditional approval filter
Authorisation status
Authorised Remove Authorised filter
Patient safety
Yes Remove Yes filter
-
List item
Human medicine European public assessment report (EPAR): Gilenya (updated)
fingolimod hydrochloride , Multiple Sclerosis
Date of authorisation: 17/03/2011,
, 
, Revision: 28, Authorised, Last updated: 04/02/2021
-
List item
Human medicine European public assessment report (EPAR): Xarelto (updated)
rivaroxaban, Arthroplasty, Replacement, Venous Thromboembolism
Date of authorisation: 30/09/2008,, , Revision: 33, Authorised, Last updated: 02/02/2021
-
List item
Human medicine European public assessment report (EPAR): Xeljanz
tofacitinib citrate, Arthritis, Rheumatoid
Date of authorisation: 21/03/2017,
Date of refusal: 25/04/2013,, , Revision: 16, Authorised, Last updated: 28/01/2021
-
List item
Human medicine European public assessment report (EPAR): Lemtrada
alemtuzumab, Multiple Sclerosis
Date of authorisation: 12/09/2013,, , Revision: 10, Authorised, Last updated: 21/07/2020